HC reserves order on Natco's plea over patent for Novartis drug

Natco has argued before Justice C Hari Shankar against the grant of patent by IPO to the pharmaceutical composition comprising combination of sacubitril + valsartan as a sodium salt complex of the Vymada.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news